Search results
Results From The WOW.Com Content Network
The bill was signed into law on February 26, 2021. Effective July 1, 2021. Idaho Medical Marijuana Act: Initiative February 11, 2021: Medical On February 11, the Idaho Secretary of State approved the Idaho Medical Marijuana Act initiative for signature collection. [38] Personal Adult Marijuana Decriminalization Act Initiative July 9, 2021 ...
Advocates say it's one step closer to full legalization of marijuana at the federal level, but Indiana and other states have a lot of catching up to do. ... important 2025 retirement account law ...
Indiana's legislative leaders, with whom the power to change the state's marijuana laws lie, are talking about this change at the federal level, even if they didn't assign the topic to an interim ...
A new Indiana governor could change the tone at the ... “My family’s history of battling addiction and law enforcement’s stand against marijuana lead me to believe now is not the time for ...
The Marijuana Opportunity Reinvestment and Expungement Act, also known as the MORE Act, is a proposed piece of U.S. federal legislation that would deschedule cannabis from the Controlled Substances Act and enact various criminal and social justice reforms related to cannabis, including the expungement of prior convictions.
Sensible Enforcement of Cannabis Act. Proposed 2019 legislation to protect cannabis businesses and consumers in states where cannabis has been legalized, into law. [2] Like the REFER Act and STATES Act, this legislation would allow federal cannabis prohibition to remain in place in states where cannabis has not been legalized. [3]
Indiana gubernatorial candidate Jennifer McCormick fielded questions from a crowded union hall Tuesday evening. Utilities, marijuana, Project 2025: Indiana governor hopeful holds Evansville town ...
Timeline of Gallup polls in US on legalizing marijuana. [1]In the United States, cannabis is legal in 39 of 50 states for medical use and 24 states for recreational use. At the federal level, cannabis is classified as a Schedule I drug under the Controlled Substances Act, determined to have a high potential for abuse and no accepted medical use, prohibiting its use for any purpose. [2]